ArticlebioRxiv : the preprint server for biology2025

Capacity for compensatory cyclin D2 response confers trametinib resistance in canine mucosal melanoma.

Bih-Rong Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.